Healthcare Industry News: joint replacement
News Release - January 31, 2008
Wright Medical Group, Inc. Launches BIOFOAM(TM) Cancellous Titanium Tibial Base for Total Knee ReplacementNew Bone-Like Titanium Offers "Fixation With Bite"
ARLINGTON, Tenn.--(HSMN NewsFeed)--Wright Medical Group, Inc. (NASDAQ: WMGI ) today announced a limited launch of the BIOFOAM™ Cancellous Titanium Tibial Base. The latest addition to Wright’s ADVANCE® Knee Systems, the BIOFOAM™ Tibial Base features a proprietary bone-like titanium with a roughened texture that “bites” into bone for cementless fixation of the implant. BIOFOAM™ Titanium also features a trabecular structure intended to mimic bone and contribute to bone in-growth.
Cementless fixation is a growing trend in knee reconstruction due to younger patients resulting from active lifestyles and increased body weight. It is theorized that cementless knees may have longer survivorship than cemented designs. One of the most important requirements to achieving solid bone in-growth in a cementless knee is immediate, rigid fixation of the implant to the bone. The rough surface of BIOFOAM™ Titanium is designed to “bite” into bone and enhance fixation. It also features a trabecular structure intended to mimic bone and contribute to in-growth.
Commenting on his surgical experiences with Wright’s BIOFOAM™ Titanium advanced surface material, Associate Professor of Orthopaedic Surgery and Director of the joint replacement Center at the Medical College of Georgia, R. Scott Corpe, M.D. stated, “I believe there is quicker in-growth into the BIOFOAM™ base [than in-growth into an HA-coated base]. Combine the BIOFOAM™ [base] with the ease and accuracy of putting this knee in with the ODYSSEY® instruments, and the ADVANCE® knee is a great product with superb intraoperative flexibility capable of handling 99% of primary knee demands.”
Mike Carroll, Senior Director of Wright’s Implant Technology Group noted, “Wright Medical has established itself as a market leader in innovative products and is committed to remaining at the forefront of orthopaedic advancements like cementless fixation. Like the ADVANCE STATURE™ femoral components, BIOFOAM™ Titanium delivers tailored options designed to meet the needs of practically any patient.”
Wright’s initial introduction of the BIOFOAM™ Titanium Tibial Base will occur through a targeted market launch, with availability of the product expanding as 2008 progresses.
Wright Medical Group, Inc. is a global orthopaedic device company specializing in the design, manufacture and marketing of reconstructive joint devices and biologics. The Company has been in business for over 50 years and markets its products in over 60 countries worldwide. For more information about Wright Medical, visit our website at www.wmt.com.
This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements made in this press release, other than statements of historical fact, are forward-looking statements. Forward-looking statements reflect management's current knowledge, assumptions, beliefs, estimates, and expectations and express management's current views of future performance, results, and trends and may be identified by their use of terms such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “predict,” “project,” “will,” and other similar terms. The Company wishes to caution readers that actual results might differ materially from those described in the forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties, including the factors discussed in the Company’s filings with the Securities and Exchange Commission (including the Company’s annual report on Form 10-K for the year ended December 31, 2006, under the heading, “Risk Factors” and its quarterly reports), which could cause the Company’s actual results to materially differ from those described in the forward-looking statements. Although the Company believes that the forward-looking statements are accurate, there can be no assurance that any forward-looking statement will prove to be accurate. A forward-looking statement should not be regarded as a representation by the Company that the results described therein will be achieved. The Company wishes to caution readers not to place undue reliance on any forward-looking statement. The forward-looking statements are made as of the date of this press release. The Company assumes no obligation to update any forward-looking statement after this date.
Source: Wright Medical Group
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.